Neuroscience

Changing treatment can help MS patients, study finds

Monash University researchers have used the world's largest multiple sclerosis (MS) registry, MSBase, to provide evidence that will help those with MS take the best medicine for them.

Medical research

Multiple sclerosis drug works in a surprising way

Drugs called interferon betas are common treatments for multiple sclerosis (MS), reducing relapses and slowing motor function decline. Interferon beta, a protein known to contain a zinc binding pocket, is thought to reduce ...

Neuroscience

Common treatment for multiple sclerosis may prolong life

Researchers from the University of British Columbia and Vancouver Coastal Health Research Institute have found that a widely prescribed drug for multiple sclerosis (MS) is associated with longer survival for patients.

Neuroscience

Taking the reins on multiple sclerosis

Multiple sclerosis doesn't have to be an ending. With proper treatment and management, patients can manage the disease's often unpredictable nature.

Neuroscience

Management of MS in pregnancy reviewed in U.K. guideline

(HealthDay)—It is important to discuss family planning and pregnancy proactively in women of childbearing age who have multiple sclerosis (MS), according to a review published online Jan. 5 in Practical Neurology.

page 1 from 3